Article
COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants.
Current pharmaceutical design - 1 Jan 2022
Yogesh Ruchika, Srivastava Noopur, Abbas Bukhari Syed Nasir
Abstract excerpt
INTRODUCTION: SARS-CoV-2 belongs to the coronavirus family, a large family of viruses infecting avian and mammalian hosts. Accumulated mutations over time in the genome of SARS-CoV-2 have given rise to different variants differing in type and sequence. Variants that did not affect transmissibility, infectivity, and severity have gone unnoticed, and mutations that made the virus unfit for survival were eventually...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
